Lifecore Biomedical, Inc. (NASDAQ: LFCR) will participate in several investor conferences in March 2025. CEO Paul Josephs will present at the TD Cowen 45th Annual Health Care Conference on March 4 and engage in investor meetings. On March 19, he will participate in a fireside chat at the KeyBanc Capital Markets Healthcare Forum. Additionally, Lifecore will attend DCAT Week 2025 from March 17-20 in New York, involving meetings with customers and networking. A live webcast of the TD Cowen presentation will be available on their investor website, with a replay accessible afterward. Lifecore specializes in sterile injectable pharmaceutical products.